Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 11/08/2024 | 11.66 M | $108.47 M | 0.79% | 9.38% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 10.97 M | $101.99 M | 11.71% | 8.82% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 10.72 M | $99.71 M | 7.17% | 8.63% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 9.03 M | $83.97 M | 100.00% | 7.26% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 8.79 M | $81.70 M | 0.00% | 7.07% |
| VANGUARD GROUP INC | 11/13/2024 | 6.96 M | $64.75 M | 13.32% | 5.60% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 6.88 M | $64.02 M | 0.08% | 5.54% |
| STATE STREET CORP | 11/14/2024 | 5.64 M | $52.47 M | 9.87% | 4.54% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 4.25 M | $41.40 M | -4.23% | 3.42% |
| MORGAN STANLEY | 11/14/2024 | 3.78 M | $35.17 M | -4.82% | 3.04% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2024 | 3.55 M | $33.05 M | -1.73% | 2.86% |
| CITADEL ADVISORS LLC | 11/14/2024 | 3.03 M | $28.19 M | 3.36% | 2.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.47 M | $22.98 M | 2.02% | 1.99% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 2.42 M | $22.48 M | 13.27% | 1.94% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 2.33 M | $21.62 M | -7.92% | 1.87% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2024 | 2.12 M | $19.72 M | 3.89% | 1.71% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 1.78 M | $16.54 M | 84.21% | 1.43% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 1.75 M | $16.23 M | 73.22% | 1.40% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 1.59 M | $14.82 M | -4.46% | 1.28% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.59 M | $14.79 M | 96.93% | 1.28% |
| J. GOLDMAN & CO LP | 11/14/2024 | 1.49 M | $13.88 M | 13.78% | 1.20% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 1.46 M | $13.62 M | 18.89% | 1.18% |
| CANDRIAM S.C.A. | 11/13/2024 | 1.43 M | $13.27 M | 9.10% | 1.15% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.36 M | $12.63 M | -12.83% | 1.09% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.30 M | $12.06 M | 0.92% | 1.04% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.18 M | $10.94 M | 107.35% | 0.95% |
| TEJARA CAPITAL LTD | 11/13/2024 | 1.17 M | $10.84 M | -13.27% | 0.94% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.15 M | $10.67 M | 123.81% | 0.92% |
| INVESCO LTD. | 11/12/2024 | 938,484 | $8.73 M | 0.09% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 859,846 | $8.00 M | 1.00% | 0.69% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 807,650 | $7.51 M | 9.88% | 0.65% |
| LAZARD ASSET MANAGEMENT LLC | 11/14/2024 | 803,204 | $7.47 M | 123.11% | 0.65% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 693,263 | $6.45 M | -17.26% | 0.56% |
| ABRDN PLC | 10/25/2024 | 482,074 | $4.48 M | 223.81% | 0.39% |
| FISHMAN JAY A LTD/MI | 10/30/2024 | 418,000 | $3.89 M | 20.60% | 0.34% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 323,701 | $3.01 M | -70.93% | 0.26% |
| PDT PARTNERS, LLC | 11/14/2024 | 319,715 | $2.97 M | 0.00% | 0.26% |
| TWO SEAS CAPITAL LP | 11/14/2024 | 312,122 | $2.90 M | -59.05% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 311,059 | $2.89 M | -20.28% | 0.25% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 276,818 | $2.57 M | 6.68% | 0.22% |
| BARCLAYS PLC | 11/19/2024 | 253,392 | $2.36 M | 148.15% | 0.20% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 252,151 | $2.35 M | -2.02% | 0.20% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 250,000 | $12,500 | -50.00% | 0.20% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 244,386 | $2.27 M | 100.00% | 0.20% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 237,174 | $2.21 M | 730.01% | 0.19% |
| AMI ASSET MANAGEMENT CORP | 10/25/2024 | 223,681 | $2.08 M | 36.23% | 0.18% |
| UBS GROUP AG | 11/14/2024 | 220,194 | $2.05 M | -28.87% | 0.18% |
| SWISS NATIONAL BANK | 11/07/2024 | 203,600 | $1.89 M | 0.00% | 0.16% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 192,099 | $1.79 M | 100.00% | 0.15% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 182,800 | $1.70 M | -62.59% | 0.15% |
Arcutis Biotherapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 220 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:
JENNISON ASSOCIATES LLC: 11.66 M
Rubric Capital Management LP: 10.97 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 10.72 M
BlackRock Funding, Inc. /DE: 9.03 M
Frazier Life Sciences Management, L.P.: 8.79 M
VANGUARD GROUP INC: 6.96 M
103.37% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 136.14 M shares in the last 24 months. This purchase volume represents approximately $2.04 B in transactions.